Cell therapy market on track for $17.15b by 2032 amidst strong growth momentum

This is driven by strategic investments and expnding adoption amongst others.

The global cell therapy market is projected to expand at a compound annual growth rate of 15.2% from 2026 to 2032, reaching nearly US$17.15b, according to a Maximise Market Research report.

The report said it is being driven by chimeric antigen receptor T-cell, allogeneic platforms, and clustered regularly interspaced short palindromic repeats-based innovations.

Strategic investments, high-profile acquisitions, and expanding adoption across North America, Europe, and Asia-Pacific are also driving global growth.

However, the market faces hurdles, including high treatment costs, limited reimbursement policies, and complex regulatory approvals.